Previous close | 9.90 |
Open | 9.90 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 120.00 |
Expiry date | 2025-01-17 |
Day's range | 9.90 - 9.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.
In the latest trading session, Novo Nordisk (NVO) closed at $126.16, marking a -1.93% move from the previous day.